234 related articles for article (PubMed ID: 28522403)
21. Characterization of human autoantibodies reactive to gastric parietal cells.
Wang XH; Miyazaki Y; Shinomura Y; Moriyama Y; Nakamoto RK; Matsuzawa Y; Maeda M; Futai M
Biochem Biophys Res Commun; 1993 Jan; 190(1):207-14. PubMed ID: 7678490
[TBL] [Abstract][Full Text] [Related]
22. Challenges in the Standardization of Autoantibody Testing: a Comprehensive Review.
Tozzoli R; Villalta D; Bizzaro N
Clin Rev Allergy Immunol; 2017 Aug; 53(1):68-77. PubMed ID: 27498835
[TBL] [Abstract][Full Text] [Related]
23. Reference standards for the detection of anti-mitochondrial and anti-rods/rings autoantibodies.
Calise SJ; Zheng B; Hasegawa T; Satoh M; Isailovic N; Ceribelli A; Andrade LEC; Boylan K; Cavazzana I; Fritzler MJ; de la Torre IG; Hiepe F; Kohl K; Selmi C; Shoenfeld Y; Tincani A; Chan EKL;
Clin Chem Lab Med; 2018 Sep; 56(10):1789-1798. PubMed ID: 29478040
[TBL] [Abstract][Full Text] [Related]
24. Autoantibodies to parietal cells as predictors of atrophic body gastritis: a five-year prospective study in patients with autoimmune thyroid diseases.
Tozzoli R; Kodermaz G; Perosa AR; Tampoia M; Zucano A; Antico A; Bizzaro N
Autoimmun Rev; 2010 Dec; 10(2):80-3. PubMed ID: 20696284
[TBL] [Abstract][Full Text] [Related]
25. High Prevalence of Autoimmune Gastritis in Patients with Nonalcoholic Steatohepatitis.
Kawanaka M; Tanikawa T; Kamada T; Ishii K; Urata N; Nakamura J; Nishino K; Suehiro M; Sasai T; Manabe N; Monobe Y; Kawamoto H; Haruma K
Intern Med; 2019 Oct; 58(20):2907-2913. PubMed ID: 31292380
[TBL] [Abstract][Full Text] [Related]
26. Clinical correlation of antimitochondrial antibodies.
Zuber MA; Recktenwald C
Eur J Med Res; 2003 Feb; 8(2):61-70. PubMed ID: 12626283
[TBL] [Abstract][Full Text] [Related]
27. Prevalence of gastric parietal cell antibodies and intrinsic factor antibodies in primary biliary cirrhosis.
Liaskos C; Norman GL; Moulas A; Garagounis A; Goulis I; Rigopoulou EI; Dalekos GN
Clin Chim Acta; 2010 Mar; 411(5-6):411-5. PubMed ID: 20026019
[TBL] [Abstract][Full Text] [Related]
28. [Autoimmune reactions in diseases of the digestive system organs].
Tsaregorodtseva TM; Serova TI; Vinnitskaia EV; Sabel'nikova EA; Berezina OV
Ter Arkh; 2009; 81(2):68-71. PubMed ID: 19334495
[TBL] [Abstract][Full Text] [Related]
29. Mucocutaneous Manifestations in Autoimmune Gastritis: A Prospective Case-Control Study.
Gonzalez A; Latorre G; Paredes L; Montoya L; Maquilon S; Shah SC; Espino A; Sabatini N; Torres J; Roa JC; Riquelme A; Kolbach M
Am J Gastroenterol; 2021 Dec; 116(12):2374-2384. PubMed ID: 34665156
[TBL] [Abstract][Full Text] [Related]
30. Anti-parietal cell antibody in autoimmune liver diseases is associated with gastric mucosal atrophy and intestinal metaplasia.
Oya H; Uchida Y; Morshed SA; Nishioka M
Adv Exp Med Biol; 1995; 371B():1087-9. PubMed ID: 7502759
[No Abstract] [Full Text] [Related]
31. [The clinical laboratory in the diagnosis of autoimmune liver diseases].
Muñoz LE; del Rocío Ayala SR
Rev Gastroenterol Mex; 1993; 58(2):164-9. PubMed ID: 7747027
[TBL] [Abstract][Full Text] [Related]
32. Detection of serum M2 anti-mitochondrial antibodies by enzyme-linked immunosorbent assay is potentially less specific than by immunofluorescence.
Patel D; Egner W; Gleeson D; Wild G; Ward A
Ann Clin Biochem; 2002 May; 39(Pt 3):304-7. PubMed ID: 12038605
[TBL] [Abstract][Full Text] [Related]
33. Diagnostic criteria and endoscopic and histological findings of autoimmune gastritis in Japan.
Kamada T; Watanabe H; Furuta T; Terao S; Maruyama Y; Kawachi H; Kushima R; Chiba T; Haruma K
J Gastroenterol; 2023 Mar; 58(3):185-195. PubMed ID: 36855000
[TBL] [Abstract][Full Text] [Related]
34. Value of autoantibody analysis in the differential diagnosis of chronic cholestatic liver disease.
Milkiewicz P; Buwaneswaran H; Coltescu C; Shums Z; Norman GL; Heathcote EJ
Clin Gastroenterol Hepatol; 2009 Dec; 7(12):1355-60. PubMed ID: 19631286
[TBL] [Abstract][Full Text] [Related]
35. A novel and effective approach of developing aggressive experimental autoimmune gastritis in neonatal thymectomized BALB/c mouse by polyinosinic:polycytidylic acid.
Kobayashi Y; Murakami H; Akbar SM; Matsui H; Onji M
Clin Exp Immunol; 2004 Jun; 136(3):423-31. PubMed ID: 15147343
[TBL] [Abstract][Full Text] [Related]
36. [A rare combination of two autoimmune diseases (scleroderma, primary biliary cirrhosis) in relation to parietal cell antibodies].
Becker-Müller S; Kühn H; Stadelmann O
Leber Magen Darm; 1991 Jun; 21(4):170-2. PubMed ID: 1943432
[TBL] [Abstract][Full Text] [Related]
37. Clinical profiles, endoscopic and laboratory features and associated factors in patients with autoimmune gastritis.
Soykan I; Yakut M; Keskin O; Bektaş M
Digestion; 2012; 86(1):20-6. PubMed ID: 22710370
[TBL] [Abstract][Full Text] [Related]
38. Oxyntic gastric atrophy in Helicobacter pylori gastritis is distinct from autoimmune gastritis.
Venerito M; Varbanova M; Röhl FW; Reinhold D; Frauenschläger K; Jechorek D; Weigt J; Link A; Malfertheiner P
J Clin Pathol; 2016 Aug; 69(8):677-85. PubMed ID: 26729016
[TBL] [Abstract][Full Text] [Related]
39. [Detection of anti-ENA and anti-dsDNA antibodies using line immunoassay in systemic autoimmune diseases].
Kim JM; Ihm CH; Sin DH; Ihm MK; Sim SC
Korean J Lab Med; 2008 Oct; 28(5):353-61. PubMed ID: 18971616
[TBL] [Abstract][Full Text] [Related]
40. [Autoimmune hepatitis and overlap syndrome: diagnosis].
Berg PA; Klein R
Praxis (Bern 1994); 2002 Aug; 91(34):1339-46. PubMed ID: 12233264
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
